$BGS

Insider Buying Week 05-17-24 Biotech Bonanza

by

I was a little late in finishing the blog, as there were many more names to research. Most of the quarterly earnings are behind us, and it is heartening to see that insider buying has picked up a little. Speculative biotech is heating up.   Name: F Thomson Leighton Position: Chief Executive Officer Transaction Date: 2023-05-14 Shares Bought: 22,000 Average Price Paid: $92.68 Cost: $2,038,960 Company: Akamai Technologies Inc (AKAM) Akamai aims to empower and defend life online. Since 1998, Akamai has created and delivered technologies to help global businesses design, deliver, and protect their digital experiences on their widely … Read more

Massimo and Apple Showdown coming soon to a screen near you-other notable Insider Buys

by

Learn How You Can Become an Insider Too – Click Here   The reality of significantly richer returns on risk-free assets like U.S. Treasuries has taken hold of investors’ psyches. The marginal excess returns that the stock market is likely to provide over the 10 Year Treasury are still mildly attractive. Considering the historic return of the stock market is 7.5%-8%, is the 3.7% to 4.18% risk premium above yesterday’s 3.82% 10 Year Treasury Yield worth it?  For some retired investors losing sleep over the market’s gut-wrenching volatility- the answer is clearly no.  Years of financial repression are over for … Read more